To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene RALGPS2TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
278 supporting clones for gene RALGPS2 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
DB081864 testis RALGPS2.a 1 to 356 2 to 358   tiling clone, capped   357/365
(97 %)
5 diff
(98.7 %id)
DB448464 testis RALGPS2.a 78 to 491 1 to 419       419/419
(100 %)
20 diff
(95.3 %id)
BI559980 testis RALGPS2.a 83 to 724 1 to 655   tiling clone,   655/655
(100 %)
26 diff
(96.1 %id)
TI_44348632   RALGPS2.a 83 to 652 127 to 704       578/780
(74 %)
15 diff
(98.1 %id)
CD243398 testis RALGPS2.a 95 to 875 1 to 790       788/931
(84 %)
22 diff
(97.7 %id)
BI561565 testis RALGPS2.a 96 to 775 1 to 683       683/683
(100 %)
12 diff
(98.3 %id)
BC047391 testis RALGPS2.a 101 to 2538 1 to 2441 exact tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (21/21 A in genome downstream of last aligned base) 2441/2443
(99 %)
4 diff
(99.9 %id)
TI_44350784   RALGPS2.a 101 to 775 124 to 801       678/801
(84 %)
11 diff
(98.7 %id)
NM_152663.3   RALGPS2.a 101 to 5934 1 to 5834 exact RefSeq,   5834/5834
(100 %)
0 diff
(100 %id)
DB095588 testis RALGPS2.a 103 to 665 2 to 568   capped   567/567
(100 %)
6 diff
(99.0 %id)
DB444941 testis RALGPS2.a 130 to 555 1 to 429       429/429
(100 %)
11 diff
(97.5 %id)
DB452908 testis RALGPS2.a 130 to 620 1 to 494       494/494
(100 %)
3 diff
(99.4 %id)
BI463390 testis RALGPS2.a 131 to 820 1 to 705       703/731
(96 %)
48 diff
(93.5 %id)
BI460058 testis RALGPS2.a 137 to 758 1 to 626       626/626
(100 %)
12 diff
(98.1 %id)
BI461346 testis RALGPS2.a 137 to 825 1 to 687       687/800
(85 %)
24 diff
(97.0 %id)
CD557616 testis RALGPS2.a 148 to 961 1 to 821       821/872
(94 %)
11 diff
(98.8 %id)
DB444644 testis RALGPS2.a 149 to 570 1 to 425       425/425
(100 %)
4 diff
(99.1 %id)
DB447663 testis RALGPS2.a 149 to 569 1 to 424       424/424
(100 %)
5 diff
(98.9 %id)
DB448278 testis RALGPS2.a 149 to 572 1 to 428       428/428
(100 %)
6 diff
(98.6 %id)
DB449801 testis RALGPS2.a 149 to 583 1 to 438       438/438
(100 %)
4 diff
(99.1 %id)
DB453987 testis RALGPS2.a 149 to 621 1 to 476       476/476
(100 %)
3 diff
(99.4 %id)
DB456594 testis RALGPS2.a 154 to 356 1 to 207       207/293
(70 %)
5 diff
(98.3 %id)
BP316162 pericardium RALGPS2.a 168 to 687 1 to 524   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 524/539
(97 %)
5 diff
(99.1 %id)
DA757366   RALGPS2.a 170 to 730 2 to 566   capped   565/565
(100 %)
3 diff
(99.5 %id)
BP229746 brain RALGPS2.a 180 to 757 1 to 582       582/582
(100 %)
4 diff
(99.4 %id)
BP363799 lung RALGPS2.a 180 to 762 1 to 587       587/587
(100 %)
4 diff
(99.4 %id)
DA618075   RALGPS2.a 181 to 752 2 to 576   capped   575/575
(100 %)
2 diff
(99.7 %id)
DB023368 testis RALGPS2.a 181 to 733 2 to 557   capped   556/556
(100 %)
2 diff
(99.7 %id)
DB033740 testis RALGPS2.a 181 to 756 2 to 581   capped   580/580
(100 %)
3 diff
(99.5 %id)
AL701277 human skeletal muscle RALGPS2.a 188 to 744 1 to 560       560/560
(100 %)
3 diff
(99.5 %id)
BI464508 testis RALGPS2.a 194 to 952 26 to 783       758/794
(95 %)
15 diff
(98.2 %id)
BI461606 testis RALGPS2.a 194 to 909 26 to 735   tiling clone,   710/738
(96 %)
11 diff
(98.6 %id)
AL598183   RALGPS2.a 196 to 680 1 to 485       485/485
(100 %)
2 diff
(99.6 %id)
DR002330 fetal brain RALGPS2.a 197 to 859 1 to 663       663/663
(100 %)
5 diff
(99.3 %id)
BQ707920 Spleen RALGPS2.a 201 to 1049 1 to 853   tiling clone,   853/949
(89 %)
16 diff
(98.4 %id)
CD698952 normal nasopharynx RALGPS2.a 226 to 673 30 to 477       448/477
(93 %)
6 diff
(98.8 %id)
BP233645 coronary artery RALGPS2.a 234 to 815 1 to 582       582/582
(100 %)
6 diff
(99.0 %id)
BP245837 Kidney RALGPS2.a 239 to 834 1 to 596       596/596
(100 %)
0 diff
(100 %id)
BM714040 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid RALGPS2.a 244 to 675 1 to 432   fully sequenced, AAA   432/432
(100 %)
1 diff
(99.8 %id)
BX642741   RALGPS2.a 270 to 751 1 to 482       482/482
(100 %)
1 diff
(99.8 %id)
CN483501 eye RALGPS2.a 280 to 925 1 to 646       646/646
(100 %)
0 diff
(100 %id)
DB055874 testis RALGPS2.a 321 to 849 2 to 531   capped   530/530
(100 %)
1 diff
(99.9 %id)
DB068777 testis RALGPS2.a 323 to 864 2 to 545   capped   544/544
(100 %)
2 diff
(99.7 %id)
BF002534 colon, colon tumor, RER+ RALGPS2.a 352 to 681 331 to 2       330/346
(95 %)
3 diff
(99.2 %id)
AA262920 germinal center B cell RALGPS2.a 393 to 675 1 to 283     Submitted on the opposite strand 283/283
(100 %)
1 diff
(99.7 %id)
BM674654 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid RALGPS2.a 465 to 675 226 to 16   fully sequenced, AAA   211/211
(100 %)
0 diff
(100 %id)
BG574393 breast, mammary adenocarcinoma, cell line RALGPS2.a 497 to 1332 1 to 838       838/841
(99 %)
7 diff
(99.2 %id)
BE081328 breast RALGPS2.a 542 to 980 15 to 453       439/453
(96 %)
12 diff
(97.4 %id)
DB077214 testis RALGPS2.a 613 to 1187 2 to 576   capped   575/575
(100 %)
2 diff
(99.7 %id)
AA252781 germinal center B cell RALGPS2.a 691 to 1117 430 to 4     Submitted on the opposite strand 427/430
(99 %)
1 diff
(99.8 %id)
DB458809 testis RALGPS2.a 913 to 1365 1 to 453       453/453
(100 %)
0 diff
(100 %id)
CN430798 embryonic stem cells, DMSO-treated H9 cellline RALGPS2.a 1137 to 1523 1 to 387       387/387
(100 %)
0 diff
(100 %id)
BM460749 leiomyosarcoma, uterus RALGPS2.a 1239 to 2162 1 to 930       928/1038
(89 %)
23 diff
(97.8 %id)
AA641979 germinal center B cell RALGPS2.a 1311 to 1562 1 to 252       252/252
(100 %)
0 diff
(100 %id)
BM702469 eye, optic nerve RALGPS2.a 1906 to 2447 1 to 542   AAA Possibly primed on the genome, locally A rich (21/21 A in genome downstream of last aligned base) 542/542
(100 %)
0 diff
(100 %id)
TI_153963475   RALGPS2.a 1906 to 2447 74 to 615   AAA Possibly primed on the genome, locally A rich (21/21 A in genome downstream of last aligned base) 542/542
(100 %)
0 diff
(100 %id)
BM666765 eye, human retina RALGPS2.a 1908 to 2447 558 to 19   AAA Possibly primed on the genome, locally A rich (21/21 A in genome downstream of last aligned base) 540/551
(98 %)
0 diff
(100 %id)
BQ186447 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid RALGPS2.a 1945 to 2447 1 to 503   fully sequenced, AAA Possibly primed on the genome, locally A rich (21/21 A in genome downstream of last aligned base) 503/503
(100 %)
0 diff
(100 %id)
TI_151730490   RALGPS2.a 1960 to 2447 570 to 83   AAA Possibly primed on the genome, locally A rich (21/21 A in genome downstream of last aligned base) 488/991
(49 %)
1 diff
(99.9 %id)
BX112360 breast RALGPS2.a 1965 to 2287 1 to 321   AAA   321/383
(83 %)
9 diff
(97.7 %id)
H45120 breast RALGPS2.a 1965 to 2287 1 to 322       322/395
(81 %)
10 diff
(97.5 %id)
H44693 breast RALGPS2.a 1965 to 2276 1 to 317       317/358
(88 %)
12 diff
(96.7 %id)
AW274297 pooled RALGPS2.a 1996 to 2449 454 to 1       454/454
(100 %)
0 diff
(100 %id)
DB506997 testis RALGPS2.a 2004 to 2467 14 to 470     Submitted on the opposite strand 457/470
(97 %)
9 diff
(98.1 %id)
DB276374 uterus RALGPS2.a 2007 to 2554 2 to 549   capped   548/548
(100 %)
1 diff
(99.9 %id)
AL706396 human skeletal muscle RALGPS2.a 2008 to 2436 1 to 431       429/431
(99 %)
7 diff
(98.4 %id)
CD707829 normal nasopharynx RALGPS2.a 2016 to 2620 22 to 626       605/626
(96 %)
6 diff
(99.1 %id)
DB547688 hippocampus RALGPS2.a 2047 to 2480 1 to 434     Submitted on the opposite strand 434/434
(100 %)
0 diff
(100 %id)
BI090473 cervix RALGPS2.a 2067 to 2764 10 to 708       699/709
(98 %)
14 diff
(98.1 %id)
BU934741 mixed (pool of 40 RNAs) RALGPS2.a 2080 to 2846 1 to 774   tiling clone,   774/840
(92 %)
18 diff
(97.9 %id)
DB509917 testis RALGPS2.a 2084 to 2540 1 to 457     Submitted on the opposite strand 457/457
(100 %)
1 diff
(99.8 %id)
BI601308 brain, hypothalamus RALGPS2.a 2126 to 2791 1 to 664       664/758
(87 %)
7 diff
(99.1 %id)
BI601665 brain, hypothalamus RALGPS2.a 2126 to 2781 1 to 657   available from MGC,   657/657
(100 %)
20 diff
(97.0 %id)
TI_45210634   RALGPS2.a 2130 to 2886 90 to 843       733/843
(86 %)
22 diff
(97.4 %id)
TI_45214721   RALGPS2.a 2130 to 2781 90 to 742       653/742
(88 %)
23 diff
(97.0 %id)
CK300972 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid RALGPS2.a 2130 to 2447 336 to 19   fully sequenced, AAA Possibly primed on the genome, locally A rich (21/21 A in genome downstream of last aligned base) 318/318
(100 %)
0 diff
(100 %id)
DB492902 hypothalamus RALGPS2.a 2131 to 2582 1 to 451       451/462
(97 %)
2 diff
(99.6 %id)
BC045691 Brain, hypothalamus RALGPS2.a 2131 to 5931 1 to 3801   tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (21/21 A in genome downstream of last aligned base) 3801/3801
(100 %)
5 diff
(99.9 %id)
BP368117 thymus RALGPS2.a 2182 to 2762 1 to 580       580/580
(100 %)
1 diff
(99.9 %id)
CN299720 embryonic stem cells, cell lines H1, H7, andH9 RALGPS2.a 2200 to 2521 1 to 322       322/322
(100 %)
0 diff
(100 %id)
BF327215 breast_normal RALGPS2.a 2228 to 2764 16 to 551       536/552
(97 %)
8 diff
(98.6 %id)
CN276643 embryonic stem cells, DMSO-treated H9 cellline RALGPS2.a 2253 to 2379 8 to 134       127/134
(94 %)
6 diff
(95.6 %id)
CF137599 lymph RALGPS2.a 2323 to 2764 8 to 449       442/449
(98 %)
6 diff
(98.7 %id)
TI_154167107   RALGPS2.a 2323 to 2784 81 to 542       462/462
(100 %)
1 diff
(99.8 %id)
N42772 melanocyte RALGPS2.a 2335 to 2645 1 to 313       313/324
(96 %)
8 diff
(97.6 %id)
AW503838 lymph RALGPS2.a 2370 to 2752 1 to 384       384/384
(100 %)
6 diff
(98.5 %id)
TI_154159835   RALGPS2.a 2377 to 3020 90 to 721       632/666
(94 %)
38 diff
(94.3 %id)
BI462241 testis RALGPS2.a 2422 to 3200 1 to 774       774/774
(100 %)
20 diff
(97.5 %id)
AW504453 lymph RALGPS2.a 2590 to 3087 1 to 498       498/498
(100 %)
6 diff
(98.8 %id)
TI_154160649   RALGPS2.a 2597 to 3290 81 to 763       683/696
(98 %)
28 diff
(96.0 %id)
DB513673 testis RALGPS2.a 2675 to 3051 1 to 379     Submitted on the opposite strand 379/379
(100 %)
14 diff
(96.4 %id)
BF327618 breast_normal RALGPS2.a 2704 to 3133 38 to 467       430/473
(90 %)
3 diff
(99.4 %id)
BU508028 leiomyosarcoma, uterus RALGPS2.a 2764 to 3124 1 to 365       365/985
(37 %)
12 diff
(98.8 %id)
AA018340 eye, retina RALGPS2.a 2818 to 3145 1 to 333       333/343
(97 %)
6 diff
(98.3 %id)
BU428869 lymph RALGPS2.a 2853 to 3305 8 to 460       453/460
(98 %)
6 diff
(98.7 %id)
TI_154149764   RALGPS2.a 2853 to 3325 83 to 555       473/473
(100 %)
0 diff
(100 %id)
AW977363   RALGPS2.a 2863 to 3548 691 to 1     Submitted on the opposite strand 691/696
(99 %)
12 diff
(98.3 %id)
BX952721   RALGPS2.a 2871 to 3135 1 to 265       265/265
(100 %)
0 diff
(100 %id)
DB077781 testis RALGPS2.a 2955 to 3528 2 to 575   capped   574/574
(100 %)
0 diff
(100 %id)
DB454304 testis RALGPS2.a 2968 to 3434 1 to 467       467/467
(100 %)
2 diff
(99.6 %id)
N31935 melanocyte RALGPS2.a 3003 to 3568 569 to 1       569/569
(100 %)
9 diff
(98.5 %id)
BX118858   RALGPS2.a 3021 to 3737 1 to 717       717/717
(100 %)
1 diff
(99.9 %id)
AA460997   RALGPS2.a 3021 to 3338 1 to 318       318/318
(100 %)
0 diff
(100 %id)
DA306067 hippocampus RALGPS2.a 3033 to 3627 2 to 596   capped   595/595
(100 %)
0 diff
(100 %id)
DA728440   RALGPS2.a 3042 to 3768 2 to 731   capped   730/752
(97 %)
8 diff
(99.0 %id)
AI433732 Kidney RALGPS2.a 3066 to 3568 513 to 11   AAA Possibly primed on the genome, locally A rich (21/21 A in genome downstream of last aligned base) 503/503
(100 %)
0 diff
(100 %id)
AL701189 human skeletal muscle RALGPS2.a 3075 to 3622 1 to 548       548/548
(100 %)
0 diff
(100 %id)
N20982 melanocyte RALGPS2.a 3089 to 3568 481 to 1       481/481
(100 %)
6 diff
(98.8 %id)
DB519670 testis RALGPS2.a 3118 to 3567 1 to 450     Submitted on the opposite strand 450/451
(99 %)
1 diff
(99.8 %id)
DB511095 testis RALGPS2.a 3127 to 3567 1 to 441     Submitted on the opposite strand 441/442
(99 %)
9 diff
(98.0 %id)
DB515088 testis RALGPS2.a 3135 to 3570 1 to 434     Submitted on the opposite strand 434/439
(98 %)
6 diff
(98.7 %id)
AA736780 germinal center B cell RALGPS2.a 3196 to 3558 363 to 1       363/363
(100 %)
0 diff
(100 %id)
DB512874 testis RALGPS2.a 3198 to 3567 1 to 371     Submitted on the opposite strand 371/372
(99 %)
6 diff
(98.4 %id)
DB518366 testis RALGPS2.a 3202 to 3568 1 to 367     Submitted on the opposite strand 367/367
(100 %)
0 diff
(100 %id)
DB512724 testis RALGPS2.a 3239 to 3567 1 to 331     Submitted on the opposite strand 331/332
(99 %)
6 diff
(98.2 %id)
AA721230 germinal center B cell RALGPS2.a 3258 to 3568 340 to 30   AAA Possibly primed on the genome, locally A rich (21/21 A in genome downstream of last aligned base) 311/311
(100 %)
0 diff
(100 %id)
DB512511 testis RALGPS2.a 3330 to 3570 1 to 242     Submitted on the opposite strand 242/247
(97 %)
3 diff
(98.8 %id)
DN912592   RALGPS2.a 3511 to 4037 1 to 525       525/525
(100 %)
8 diff
(98.5 %id)
BF033127 adenocarcinoma, ovary RALGPS2.a 3668 to 4338 1 to 673   tiling clone,   673/674
(99 %)
14 diff
(98.0 %id)
CN371312 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells RALGPS2.a 3718 to 4342 1 to 625       625/625
(100 %)
1 diff
(99.9 %id)
CN371311 embryonic stem cells, DMSO-treated H9 cellline RALGPS2.a 3765 to 4259 1 to 495   tiling clone,   495/495
(100 %)
0 diff
(100 %id)
AA460650   RALGPS2.a 3866 to 4213 355 to 8       348/355
(98 %)
0 diff
(100 %id)
BU172024 melanotic melanoma, skin RALGPS2.a 4211 to 5099 1 to 898       898/898
(100 %)
11 diff
(98.8 %id)
BF375057 stomach RALGPS2.a 4258 to 4905 1 to 646       646/655
(98 %)
15 diff
(97.8 %id)
BE002979 breast_normal RALGPS2.a 4356 to 4709 356 to 4     Submitted on the opposite strand 353/356
(99 %)
0 diff
(100 %id)
BE896122 melanotic melanoma, skin RALGPS2.a 4382 to 5062 1 to 671       671/933
(71 %)
28 diff
(97.0 %id)
CF142669 lymph RALGPS2.a 4437 to 4913 7 to 483       477/483
(98 %)
6 diff
(98.8 %id)
TI_154173737   RALGPS2.a 4437 to 5075 79 to 721       643/662
(97 %)
16 diff
(97.6 %id)
AL042521 testis RALGPS2.a 4583 to 5229 1 to 654       654/655
(99 %)
9 diff
(98.7 %id)
BE244353 leukopheresis RALGPS2.a 4619 to 5085 467 to 1       467/467
(100 %)
3 diff
(99.4 %id)
BM151658 leukopheresis RALGPS2.a 4632 to 5085 454 to 1       454/454
(100 %)
6 diff
(98.7 %id)
BI871201 adenocarcinoma, cell line, Liver RALGPS2.a 4650 to 5481 1 to 833       833/833
(100 %)
15 diff
(98.2 %id)
TI_57230418   RALGPS2.a 4650 to 5481 87 to 919       833/833
(100 %)
15 diff
(98.2 %id)
BE244040 leukopheresis RALGPS2.a 4694 to 5085 392 to 1       392/392
(100 %)
1 diff
(99.8 %id)
CN359698 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells RALGPS2.a 4710 to 5317 1 to 609       609/609
(100 %)
4 diff
(99.4 %id)
BP431855   RALGPS2.a 4742 to 4978 1 to 237       237/237
(100 %)
4 diff
(98.4 %id)
BE865908 bladder, carcinoma, cell line RALGPS2.a 4803 to 5286 1 to 485       485/485
(100 %)
10 diff
(98.0 %id)
BU569295 testis RALGPS2.a 4828 to 5573 1 to 751       751/811
(92 %)
12 diff
(98.6 %id)
FN160347 breast carcinoma RALGPS2.a 4852 to 4949 95 to 1     Submitted on the opposite strand 95/95
(100 %)
3 diff
(96.9 %id)
BM761484 lymph node, stomach RALGPS2.a 4852 to 5456 1 to 606       606/606
(100 %)
1 diff
(99.9 %id)
BE567336 bladder, carcinoma, cell line RALGPS2.a 4879 to 5566 1 to 701       701/802
(87 %)
38 diff
(95.3 %id)
BG283783 adenocarcinoma, cell line, Prostate RALGPS2.a 4880 to 5707 1 to 830       830/877
(94 %)
23 diff
(97.4 %id)
CD103984 Pooled-Skin RALGPS2.a 4951 to 5682 1 to 735       735/735
(100 %)
5 diff
(99.4 %id)
EH309337   RALGPS2.a 4962 to 5041 1 to 80       80/80
(100 %)
0 diff
(100 %id)
AW512288 lymph node, lymphoma, follicular mixed small and largecell RALGPS2.a 5314 to 5718 408 to 4       405/408
(99 %)
0 diff
(100 %id)
AI359480 pooled germ cell tumors RALGPS2.a 5315 to 5715 402 to 1       402/402
(100 %)
2 diff
(99.6 %id)
DB308244 hippocampus RALGPS2.a 5399 to 5931 534 to 1   tiling clone,   534/534
(100 %)
2 diff
(99.7 %id)
FN063920 breast carcinoma RALGPS2.a 5668 to 5788 1 to 122       122/122
(100 %)
1 diff
(99.2 %id)
AK301753 testis RALGPS2.b 1 to 2223 1 to 2226 I395V tiling clone,   2226/2226
(100 %)
3 diff
(99.9 %id)
CF121823 lymph RALGPS2.b 909 to 1579 8 to 677       670/677
(98 %)
7 diff
(99.0 %id)
TI_154181124   RALGPS2.b 909 to 1755 72 to 915       844/845
(99 %)
17 diff
(98.0 %id)
BE243439 leukopheresis RALGPS2.b 1410 to 1847 1 to 437   tiling clone,   437/437
(100 %)
5 diff
(98.9 %id)
BM150384 leukopheresis RALGPS2.b 1410 to 1866 1 to 458       458/458
(100 %)
7 diff
(98.5 %id)
DB032120 testis RALGPS2.c 1 to 544 2 to 545   tiling clone, capped   544/544
(100 %)
1 diff
(99.9 %id)
AL041242 testis RALGPS2.c 405 to 824 1 to 421   tiling clone,   421/422
(99 %)
2 diff
(99.6 %id)
AK098470 thyroid RALGPS2.c 805 to 2395 1 to 1591   tiling clone, available from FLJ,   1591/1651
(96 %)
4 diff
(99.8 %id)
BP269610 thyroid RALGPS2.c 805 to 1381 1 to 577       577/577
(100 %)
1 diff
(99.9 %id)
AL041243 testis RALGPS2.c 4629 to 5334 746 to 49   tiling clone,   698/746
(93 %)
0 diff
(100 %id)
AK001106 whole embryo, mainly body RALGPS2.d 1 to 1891 1 to 1894 exact tiling clone, available from FLJ,   1894/1894
(100 %)
5 diff
(99.8 %id)
AU120414 whole embryo, mainly body RALGPS2.d 2 to 826 2 to 830   capped   829/829
(100 %)
6 diff
(99.3 %id)
AU146485 whole embryo, mainly body RALGPS2.d 1348 to 1891 544 to 1       544/544
(100 %)
6 diff
(98.9 %id)
AW403969 lymph RALGPS2.e 1 to 534 8 to 541   tiling clone,   534/541
(98 %)
8 diff
(98.6 %id)
TI_154140736   RALGPS2.e 1 to 574 80 to 653       574/574
(100 %)
5 diff
(99.2 %id)
BQ001567 lung, Metastatic Chondrosarcoma RALGPS2.e 530 to 1189 678 to 19   tiling clone, AAA Possibly primed on the genome, locally A rich (21/21 A in genome downstream of last aligned base) 660/668
(98 %)
0 diff
(100 %id)
BF512826   RALGPS2.f 1 to 517 532 to 16 exact tiling clone, AAA Possibly primed on the genome, locally A rich (21/21 A in genome downstream of last aligned base) 517/517
(100 %)
1 diff
(99.9 %id)
AA972030 pooled RALGPS2.f 73 to 517 444 to 1       444/445
(99 %)
4 diff
(99.2 %id)
BE537717 cervix RALGPS2.f 78 to 806 1 to 731   tiling clone,   731/842
(86 %)
22 diff
(97.4 %id)
CN299721 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells RALGPS2.f 85 to 779 1 to 695   tiling clone,   695/695
(100 %)
1 diff
(99.9 %id)
CN299719 embryonic stem cells, DMSO-treated H9 cellline RALGPS2.f 104 to 711 2 to 609       608/609
(99 %)
5 diff
(99.2 %id)
AA917496 pooled RALGPS2.f 131 to 517 387 to 1       387/387
(100 %)
4 diff
(99.0 %id)
BU561513 testis RALGPS2.g 1 to 686 1 to 695 exact tiling clone,   695/780
(89 %)
16 diff
(98.0 %id)
DR000977 fetal brain RALGPS2.h 1 to 780 8 to 787 L121X tiling clone,   780/788
(98 %)
9 diff
(98.9 %id)
DB479020 hippocampus RALGPS2.i 1 to 508 1 to 508 exact tiling clone,   508/508
(100 %)
0 diff
(100 %id)
DB076200 testis RALGPS2.j 1 to 540 2 to 541 exact tiling clone, capped   540/540
(100 %)
0 diff
(100 %id)
DB059732 testis RALGPS2.k 1 to 520 2 to 521 exact tiling clone, capped   520/520
(100 %)
0 diff
(100 %id)
DA735386   RALGPS2.l-u 1 to 843 2 to 845   tiling clone, to resequence, capped   844/844
(100 %)
7 diff
(99.2 %id)
BM721562 eye, fetal eye RALGPS2.l-u 696 to 1133 1 to 438   tiling clone,   438/438
(100 %)
0 diff
(100 %id)
BM726028 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid RALGPS2.l-u 1183 to 1819 1 to 637   tiling clone,   637/637
(100 %)
0 diff
(100 %id)
BQ004559 Chondrosarcoma, Left Pelvis RALGPS2.l-u 1790 to 2505 730 to 19   tiling clone, AAA   712/716
(99 %)
9 diff
(98.8 %id)
AW978875   RALGPS2.l-u 1847 to 2504 658 to 1   tiling clone, Submitted on the opposite strand 658/658
(100 %)
13 diff
(98.1 %id)
CN292040 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 RALGPS2.l-u 1902 to 2505 647 to 44   tiling clone, AAA Submitted on the opposite strand 604/604
(100 %)
0 diff
(100 %id)
AW003297 pooled germ cell tumors RALGPS2.l-u 1904 to 2505 616 to 15   AAA   602/602
(100 %)
1 diff
(99.9 %id)
BM682467 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid RALGPS2.l-u 1905 to 2505 619 to 19   AAA   601/601
(100 %)
4 diff
(99.4 %id)
BQ637507 eye, retina RALGPS2.l-u 1961 to 2496 1 to 536       536/536
(100 %)
2 diff
(99.7 %id)
DN912593   RALGPS2.l-u 1968 to 2505 537 to 1       537/537
(100 %)
3 diff
(99.5 %id)
AW977360   RALGPS2.l-u 1977 to 2499 532 to 6     Submitted on the opposite strand 527/533
(98 %)
0 diff
(100 %id)
AI073978 B-cell, chronic lymphotic leukemia RALGPS2.l-u 1999 to 2505 517 to 11   AAA   507/507
(100 %)
0 diff
(100 %id)
AA834995   RALGPS2.l-u 2006 to 2508 504 to 2       503/504
(99 %)
0 diff
(100 %id)
DB522010 testis RALGPS2.l-u 2022 to 2504 1 to 483     Submitted on the opposite strand 483/483
(100 %)
1 diff
(99.8 %id)
DB524306 testis RALGPS2.l-u 2026 to 2505 1 to 480     Submitted on the opposite strand 480/480
(100 %)
1 diff
(99.8 %id)
AI126591   RALGPS2.l-u 2032 to 2508 479 to 3       477/479
(99 %)
0 diff
(100 %id)
AW139781   RALGPS2.l-u 2036 to 2501 483 to 18   AAA   466/476
(97 %)
0 diff
(100 %id)
BU752375 placenta RALGPS2.l-u 2037 to 2505 486 to 18   AAA   469/469
(100 %)
2 diff
(99.6 %id)
BX116557   RALGPS2.l-u 2039 to 2505 1 to 467   AAA   467/467
(100 %)
0 diff
(100 %id)
BQ189029 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid RALGPS2.l-u 2041 to 2505 1 to 465   AAA   465/465
(100 %)
0 diff
(100 %id)
N35124 melanocyte RALGPS2.l-u 2042 to 2505 466 to 1       466/466
(100 %)
2 diff
(99.6 %id)
AA768506 germinal center B cell RALGPS2.l-u 2050 to 2505 468 to 13   AAA   456/456
(100 %)
0 diff
(100 %id)
AI082037 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus RALGPS2.l-u 2055 to 2505 451 to 1       451/451
(100 %)
0 diff
(100 %id)
AW058163 thymus, pooled RALGPS2.l-u 2056 to 2505 450 to 1       450/450
(100 %)
1 diff
(99.8 %id)
DB367637   RALGPS2.l-u 2056 to 2505 451 to 1   to resequence,   451/515
(87 %)
5 diff
(99.1 %id)
BM677185 eye, fetal eye RALGPS2.l-u 2064 to 2504 459 to 19   AAA   441/441
(100 %)
0 diff
(100 %id)
AI970380 pooled germ cell tumors RALGPS2.l-u 2069 to 2499 434 to 4       431/434
(99 %)
0 diff
(100 %id)
AW590380 pooled germ cell tumors RALGPS2.l-u 2069 to 2502 434 to 1       434/434
(100 %)
0 diff
(100 %id)
DB519747 testis RALGPS2.l-u 2071 to 2505 1 to 435     Submitted on the opposite strand 435/435
(100 %)
5 diff
(98.9 %id)
AW073260 breast, four pooled high-grade tumors, including twoprimary tumors and two metastatic to ovary RALGPS2.l-u 2073 to 2508 438 to 3       436/438
(99 %)
0 diff
(100 %id)
BF445405 pooled germ cell tumors RALGPS2.l-u 2076 to 2505 430 to 1       430/430
(100 %)
0 diff
(100 %id)
DB509563 testis RALGPS2.l-u 2079 to 2505 1 to 427     Submitted on the opposite strand 427/427
(100 %)
1 diff
(99.8 %id)
AW196376 pooled germ cell tumors RALGPS2.l-u 2079 to 2505 427 to 1       427/427
(100 %)
0 diff
(100 %id)
DB519433 testis RALGPS2.l-u 2081 to 2505 1 to 425     Submitted on the opposite strand 425/425
(100 %)
1 diff
(99.8 %id)
DB515220 testis RALGPS2.l-u 2083 to 2505 1 to 424     Submitted on the opposite strand 424/424
(100 %)
3 diff
(99.3 %id)
CB218961 mandible, pooled RALGPS2.l-u 2083 to 2505 1 to 422   AAA   422/422
(100 %)
3 diff
(99.3 %id)
DB563985 hypothalamus RALGPS2.l-u 2090 to 2505 1 to 419     Submitted on the opposite strand 419/419
(100 %)
4 diff
(99.1 %id)
BM873814   RALGPS2.l-u 2106 to 2636 1 to 532       532/532
(100 %)
2 diff
(99.7 %id)
AA635579 normal prostate, Prostate RALGPS2.l-u 2113 to 2505 393 to 1       393/393
(100 %)
6 diff
(98.5 %id)
AA970987 Kidney, kidney tumor RALGPS2.l-u 2114 to 2508 395 to 1       395/395
(100 %)
1 diff
(99.8 %id)
AI264055 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus RALGPS2.l-u 2121 to 2505 385 to 1       385/385
(100 %)
0 diff
(100 %id)
AI567903 adenocarcinoma, Pancreas RALGPS2.l-u 2128 to 2499 378 to 7       372/378
(98 %)
0 diff
(100 %id)
AA416740   RALGPS2.l-u 2137 to 2508 372 to 1       372/372
(100 %)
1 diff
(99.8 %id)
DB511616 testis RALGPS2.l-u 2143 to 2504 1 to 362     Submitted on the opposite strand 362/362
(100 %)
9 diff
(97.6 %id)
AI625277 adenocarcinoma, Pancreas RALGPS2.l-u 2151 to 2508 357 to 2       356/357
(99 %)
0 diff
(100 %id)
AI889005 2 pooled tumors (clear cell type), Kidney RALGPS2.l-u 2169 to 2507 339 to 1       339/339
(100 %)
1 diff
(99.8 %id)
AA736698 germinal center B cell RALGPS2.l-u 2177 to 2505 341 to 13   AAA   329/329
(100 %)
0 diff
(100 %id)
AI220592   RALGPS2.l-u 2209 to 2508 300 to 1       300/300
(100 %)
0 diff
(100 %id)
AI768784 2 pooled tumors (clear cell type), Kidney RALGPS2.l-u 2280 to 2502 225 to 3       223/225
(99 %)
0 diff
(100 %id)
AW190903 adenocarcinoma, Pancreas RALGPS2.l-u 2286 to 2506 221 to 1       221/221
(100 %)
0 diff
(100 %id)
DA840950 placenta RALGPS2.l-u 2385 to 2938 2 to 555   tiling clone, capped   554/554
(100 %)
0 diff
(100 %id)
DR033730 brain, Right frontal lobe RALGPS2.l-u 2565 to 3159 14 to 608       595/608
(97 %)
6 diff
(99.1 %id)
BG570265 lung RALGPS2.l-u 2784 to 3591 1 to 819       819/864
(94 %)
24 diff
(97.3 %id)
TI_151796233   RALGPS2.l-u 2906 to 3389 106 to 596   tiling clone,   491/945
(51 %)
18 diff
(98.1 %id)
AA251024 germinal center B cell RALGPS2.l-u 3120 to 3543 1 to 424       424/424
(100 %)
0 diff
(100 %id)
AA262416 germinal center B cell RALGPS2.l-u 3120 to 3587 1 to 467   tiling clone,   467/467
(100 %)
1 diff
(99.8 %id)
AA459438 germinal center B cell RALGPS2.l-u 3120 to 3526 1 to 408       408/408
(100 %)
1 diff
(99.8 %id)
BP418518 small intestine RALGPS2.l-u 3209 to 3575 1 to 370     Submitted on the opposite strand 370/371
(99 %)
4 diff
(99.0 %id)
BI033360 nervous_normal RALGPS2.l-u 3288 to 3671 407 to 23       385/422
(91 %)
0 diff
(100 %id)
BQ423246 embryonal carcinoma, cell line, testis RALGPS2.l-u 3288 to 4163 1 to 877       877/896
(97 %)
13 diff
(98.6 %id)
BU633018 cell lines, Chondrosarcoma RALGPS2.l-u 3510 to 4244 753 to 19   tiling clone, AAA   735/735
(100 %)
0 diff
(100 %id)
BE765687 nervous_tumor RALGPS2.l-u 3529 to 3781 276 to 24       253/276
(91 %)
0 diff
(100 %id)
AA732944 heart RALGPS2.l-u 3532 to 4244 699 to 1       699/750
(93 %)
31 diff
(95.9 %id)
BX092904 placenta RALGPS2.l-u 3562 to 4244 1 to 685   AAA   685/685
(100 %)
2 diff
(99.8 %id)
R63256 placenta RALGPS2.l-u 3562 to 3928 1 to 368       368/368
(100 %)
1 diff
(99.8 %id)
BQ631623 Pancreas, Purified pancreatic islet RALGPS2.l-u 3568 to 4187 1 to 620       620/620
(100 %)
1 diff
(99.9 %id)
BM703663 eye, human retina RALGPS2.l-u 3574 to 3785 1 to 212   fully sequenced,   212/212
(100 %)
0 diff
(100 %id)
BM692765 eye, Retina Foveal and Macular RALGPS2.l-u 3590 to 3784 1 to 196   fully sequenced,   196/196
(100 %)
0 diff
(100 %id)
W32046 parathyroid gland, parathyroid tumor RALGPS2.l-u 3592 to 3914 1 to 326       326/326
(100 %)
4 diff
(98.8 %id)
CK902156 Pancreas, Purified pancreatic islet RALGPS2.l-u 3603 to 4108 1 to 506     Submitted on the opposite strand 506/506
(100 %)
2 diff
(99.7 %id)
AI770069 2 pooled tumors (clear cell type), Kidney RALGPS2.l-u 3655 to 4245 593 to 3       591/593
(99 %)
0 diff
(100 %id)
AA335785 epididymis RALGPS2.l-u 3663 to 3943 1 to 281       281/281
(100 %)
0 diff
(100 %id)
TI_154111831   RALGPS2.l-u 3671 to 4244 638 to 66   AAA   573/941
(60 %)
66 diff
(93.0 %id)
AI735574 aorta RALGPS2.l-u 3688 to 4237 550 to 1       550/550
(100 %)
5 diff
(99.1 %id)
AW516128 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus RALGPS2.l-u 3697 to 4245 553 to 5       549/553
(99 %)
0 diff
(100 %id)
BI493310 cochlea, ear RALGPS2.l-u 3711 to 3813 8 to 110       103/110
(93 %)
6 diff
(94.6 %id)
BM667121 eye, fetal eyes RALGPS2.l-u 3737 to 4244 526 to 19   AAA   508/508
(100 %)
1 diff
(99.9 %id)
AI830019 lymph node, lymphoma, follicular mixed small and largecell RALGPS2.l-u 3742 to 4244 519 to 17   AAA   503/503
(100 %)
1 diff
(99.9 %id)
AI246003 adenocarcinoma, colon RALGPS2.l-u 3743 to 4244 512 to 11   AAA   502/502
(100 %)
0 diff
(100 %id)
BM671323 eye, Retina Foveal and Macular RALGPS2.l-u 3754 to 4244 509 to 19   fully sequenced, AAA   491/491
(100 %)
0 diff
(100 %id)
BM668475 eye, human retina RALGPS2.l-u 3755 to 4244 508 to 19   fully sequenced, AAA   490/490
(100 %)
1 diff
(99.8 %id)
AI366785   RALGPS2.l-u 3768 to 4245 481 to 4       478/481
(99 %)
0 diff
(100 %id)
AI540192 B-cell, chronic lymphotic leukemia RALGPS2.l-u 3769 to 4245 485 to 9       477/485
(98 %)
0 diff
(100 %id)
AI143998 uterus RALGPS2.l-u 3772 to 4239 468 to 1       468/468
(100 %)
0 diff
(100 %id)
AI218407 pooled RALGPS2.l-u 3785 to 4245 463 to 3       461/463
(99 %)
0 diff
(100 %id)
AW418936 2 pooled tumors (clear cell type), Kidney RALGPS2.l-u 3787 to 4245 461 to 3       459/461
(99 %)
0 diff
(100 %id)
AI346648 adenocarcinoma, colon RALGPS2.l-u 3795 to 4244 459 to 11   AAA   449/449
(100 %)
6 diff
(98.7 %id)
AW663059 pooled RALGPS2.l-u 3799 to 4245 449 to 3       447/449
(99 %)
0 diff
(100 %id)
CK902157 Pancreas, Purified pancreatic islet RALGPS2.l-u 3799 to 4247 462 to 14   tiling clone, Submitted on the opposite strand 449/462
(97 %)
0 diff
(100 %id)
AI190907   RALGPS2.l-u 3804 to 4245 445 to 4       442/447
(98 %)
0 diff
(100 %id)
AI190371 heart RALGPS2.l-u 3806 to 4246 441 to 1       441/441
(100 %)
1 diff
(99.8 %id)
AI304589 adenocarcinoma, colon RALGPS2.l-u 3820 to 4244 425 to 1       425/425
(100 %)
1 diff
(99.8 %id)
AA251123 germinal center B cell RALGPS2.l-u 3844 to 4244 401 to 1       401/401
(100 %)
1 diff
(99.8 %id)
AI698595 pooled RALGPS2.l-u 3868 to 4246 379 to 1       379/379
(100 %)
1 diff
(99.8 %id)
AA983593 adenocarcinoma, colon RALGPS2.l-u 3874 to 4244 370 to 1       370/371
(99 %)
3 diff
(99.2 %id)
AA947174 pooled RALGPS2.l-u 3874 to 4245 374 to 3       372/374
(99 %)
0 diff
(100 %id)
AI873557 lymph node, lymphoma, follicular mixed small and largecell RALGPS2.l-u 3881 to 4245 373 to 6       368/373
(98 %)
0 diff
(100 %id)
AI051090 parathyroid gland, parathyroid tumor RALGPS2.l-u 3894 to 4244 366 to 16   AAA   351/351
(100 %)
0 diff
(100 %id)
AA548190 adrenal adenoma, adrenal gland RALGPS2.l-u 3895 to 4245 352 to 2       351/352
(99 %)
0 diff
(100 %id)
AW316991 adenocarcinoma, Pancreas RALGPS2.l-u 3904 to 4245 343 to 2       342/343
(99 %)
0 diff
(100 %id)
AA938120 adenocarcinoma, colon RALGPS2.l-u 3939 to 4244 306 to 1       306/306
(100 %)
1 diff
(99.7 %id)
W31358 parathyroid gland, parathyroid tumor RALGPS2.l-u 3948 to 4244 298 to 1       298/298
(100 %)
1 diff
(99.7 %id)
AA709343 heart RALGPS2.l-u 3969 to 4245 277 to 1       277/277
(100 %)
2 diff
(99.3 %id)
R63210 placenta RALGPS2.l-u 3994 to 4245 255 to 1       255/255
(100 %)
4 diff
(98.5 %id)
AA653117   RALGPS2.l-u 4005 to 4245 243 to 3       241/243
(99 %)
0 diff
(100 %id)
AI497742 lymph node, lymphoma, follicular mixed small and largecell RALGPS2.l-u 4017 to 4238 222 to 1       222/222
(100 %)
1 diff
(99.6 %id)
AW448930   RALGPS2.l-u 4019 to 4244 245 to 18   AAA   228/231
(98 %)
6 diff
(97.5 %id)
AA262417 germinal center B cell RALGPS2.l-u 4033 to 4244 212 to 1       212/212
(100 %)
0 diff
(100 %id)
BE676349 B-cell, chronic lymphotic leukemia RALGPS2.l-u 4086 to 4244 177 to 19   AAA   159/159
(100 %)
1 diff
(99.4 %id)
AI498577 lymph node, lymphoma, follicular mixed small and largecell RALGPS2.l-u 4092 to 4245 157 to 4       154/157
(98 %)
0 diff
(100 %id)
AI431281 aorta RALGPS2.l-u 4097 to 4238 142 to 1       142/142
(100 %)
0 diff
(100 %id)
AI028022 B-cell, chronic lymphotic leukemia RALGPS2.l-u 4101 to 4244 164 to 21   AAA   144/144
(100 %)
1 diff
(99.4 %id)
BI493309 cochlea, ear RALGPS2.l-u 4130 to 4245 116 to 4       113/116
(97 %)
0 diff
(100 %id)
D25816   RALGPS2.l-u 4156 to 4245 1 to 90     Submitted on the opposite strand 90/95
(94 %)
1 diff
(99.0 %id)
AI524733 B-cell, chronic lymphotic leukemia RALGPS2.m-u 1 to 470 470 to 1 exact tiling clone,   470/470
(100 %)
0 diff
(100 %id)
DB446042 testis RALGPS2.n 1 to 396 1 to 401 K8* tiling clone,   401/416
(96 %)
6 diff
(98.6 %id)
BX642896.
matches multiple genes
  Gene klorabo, variant not shown         This clone was ignored, also hits gene klorabo    
BX642896.
matches multiple genes
  Gene RALGPS2, variant not shown         This clone was ignored, also hits gene klorabo    
BX642897.
matches multiple genes
  Gene klorabo, variant not shown         This clone was ignored, also hits gene klorabo    
BX642897.
matches multiple genes
  Gene RALGPS2, variant not shown         This clone was ignored, also hits gene klorabo    
AV657838 corresponding non cancerous liver tissue Gene RALGPS2, variant not shown         Submitted on the opposite strand, submitted on the opposite strand    
DB040618 testis Gene RALGPS2, variant not shown       capped This clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j, .k, .l-u, .m-u, .n Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes CI